6
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T25268 | Coblopasvir | Others | |
Coblopasvir is a pan-genotypic non-structural protein 5A (NS5A) inhibitor. It can be used to study chronic hepatitis C virus infection. | |||
T9341 | Bemnifosbuvir | AT-511 | Others , HCV Protease , SARS-CoV |
Bemnifosbuvir (AT-511) is a novel phosphoramidate prodrug of 2'-fluoro-2'-C-methylguanosine-5'-monophosphate that has potent in vitro activity against HCV. | |||
T19862 | Voxilaprevir | HCV Protease | |
Voxilaprevir is an inhibitor of hepatitis C virus (HCV) nonstructural (NS) protein 3/4A protease. | |||
T9331 | Bemnifosbuvir hemisulfate | AT-527 | HCV Protease , SARS-CoV |
Bemnifosbuvir hemisulfate (AT-527) is a potent inhibitor of HCV virus replication. | |||
T25268L | Coblopasvir dihydrochloride | Coblopasvir dihydrochloride(1312608-46-0 Free base) | HCV Protease |
Coblopasvir dihydrochloride can be used to study chronic HCV infection and is a pan-genotypic nonstructural protein 5A (NS5A) inhibitor. | |||
T3334 | Velpatasvir | GS-5816 | HCV Protease , SARS-CoV |
Velpatasvir (GS-5816), also known as GS-5816, is a potent and selective Hepatitis C virus NS5A inhibitor. GS-5816 has demonstrated pan-genotypic activity and a high barrier to resistance in HCV replicon assays. GS-5816 d... |